These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6090464)

  • 1. The stability and potency of vaccines prepared from inactivated foot-and-mouth disease virus concentrates.
    Doel TR; David DJ
    J Biol Stand; 1984 Jul; 12(3):247-55. PubMed ID: 6090464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.
    Doel TR; Chong WK
    Arch Virol; 1982; 73(2):185-91. PubMed ID: 6293410
    [No Abstract]   [Full Text] [Related]  

  • 3. International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them.
    Doel TR; Pullen L
    Vaccine; 1990 Oct; 8(5):473-8. PubMed ID: 2174597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection and inhibition of proteolytic enzyme activity in concentrated preparations of inactivated foot-and-mouth disease virus.
    Doel TR; Collen T
    J Biol Stand; 1983 Jan; 11(1):35-46. PubMed ID: 6300129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
    Rao MG; Butchaiah G; Sen AK
    Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of vaccinated pigs with foot-and-mouth disease virus.
    de Leeuw PW; Tiessink JW; van Bekkum JG
    Zentralbl Veterinarmed B; 1979 Mar; 26(2):98-109. PubMed ID: 231356
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of foot-and-mouth disease vaccines containing endonuclease-inactivated virions.
    Amadori M; Barei S; Melegari M; Panina GF
    Vaccine; 1987 Sep; 5(3):219-22. PubMed ID: 2823495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response of neonatal swine to inactivated foot-and-mouth disease virus vaccine with oil adjuvant. I. Influence of colostral antibody.
    Morgan DO; McKercher PD
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):244-55. PubMed ID: 220635
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles.
    McCullough KC; Butcher R
    Arch Virol; 1982; 74(1):1-9. PubMed ID: 6186225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction.
    Rweyemamu MM; Ouldridge EJ; Head M; Ferrari R
    J Biol Stand; 1984 Jul; 12(3):295-303. PubMed ID: 6090465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innocuity testing of foot-and-mouth disease vaccines. II. Aziridine-inactivated antigen produced in baby hamster kidney cells.
    Barteling SJ
    J Biol Stand; 1983 Oct; 11(4):305-12. PubMed ID: 6315737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the immune responses of sheep against foot-and-mouth disease virus types Asia-1 and O PEG-concentrated aluminium hydroxide gel and oil-adjuvanted vaccines.
    Nair SP; Sen AK
    Vaccine; 1993; 11(7):782-6. PubMed ID: 8393608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ; Sangar DV; Brown F
    Arch Gesamte Virusforsch; 1972; 39(1):274-83. PubMed ID: 4344146
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody response in bovine pharyngeal fluid following foot-and-mouth disease vaccination and, or, exposure to live virus.
    Francis MJ; Ouldridge EJ; Black L
    Res Vet Sci; 1983 Sep; 35(2):206-10. PubMed ID: 6314460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
    Herniman KA; Sellers RF
    Arch Gesamte Virusforsch; 1972; 37(1):97-103. PubMed ID: 4336969
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study on the immune response of sheep to foot and mouth disease virus vaccine type Asia-1 prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):117-24. PubMed ID: 1314158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations and implications of proteolysis in preparations of foot-and-mouth disease virus.
    Doel TR; Collen T
    Dev Biol Stand; 1981; 50():261-6. PubMed ID: 6281109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.